News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
293,316 Results
Type
Article (15700)
Company Profile (301)
Press Release (277309)
Multimedia
Podcasts (78)
Webinars (12)
Section
Business (85132)
Career Advice (353)
Deals (13663)
Drug Delivery (40)
Drug Development (51193)
Employer Resources (36)
FDA (5983)
Job Trends (5544)
News (151522)
Policy (10401)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1068)
Academic (1)
Accelerated approval (19)
Adcomms (14)
Allergies (86)
Alliances (22454)
ALS (127)
Alzheimer's disease (1046)
Antibody-drug conjugate (ADC) (241)
Approvals (6181)
Artificial intelligence (265)
Autoimmune disease (111)
Automation (10)
Bankruptcy (113)
Best Places to Work (4882)
BIOSECURE Act (8)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (103)
Brain cancer (45)
Breast cancer (349)
Cancer (3170)
Cardiovascular disease (243)
Career advice (327)
Career pathing (12)
CAR-T (218)
CDC (5)
Cell therapy (568)
Cervical cancer (14)
Clinical research (44081)
Collaboration (1169)
Company closure (2)
Compensation (595)
Complete response letters (40)
COVID-19 (1132)
CRISPR (88)
C-suite (591)
Cystic fibrosis (112)
Data (4382)
Denatured (15)
Depression (92)
Diabetes (261)
Diagnostics (1518)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (11)
Drug discovery (189)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (32439)
Editorial (25)
Employer branding (4)
Employer resources (34)
Events (52833)
Executive appointments (669)
FDA (7772)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (997)
Gene editing (184)
Generative AI (22)
Gene therapy (489)
GLP-1 (510)
Government (1199)
Grass and pollen (3)
Guidances (172)
Healthcare (7132)
HIV (19)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (194)
Immuno-oncology (39)
Indications (67)
Infectious disease (1238)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (39)
Intellectual property (168)
Interviews (40)
IPO (7513)
IRA (13)
Job creations (921)
Job search strategy (281)
JPM (42)
Kidney cancer (9)
Labor market (24)
Layoffs (254)
Leadership (10)
Legal (1464)
Liver cancer (42)
Longevity (11)
Lung cancer (422)
Lymphoma (249)
Machine learning (24)
Management (8)
Manufacturing (395)
MASH (130)
Medical device (2929)
Medtech (2939)
Mergers & acquisitions (6775)
Metabolic disorders (733)
Multiple sclerosis (109)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (71)
Neuroscience (1979)
Neurotech (1)
NextGen: Class of 2026 (2240)
Non-profit (1079)
Now hiring (30)
Obesity (331)
Opinion (132)
Ovarian cancer (131)
Pain (106)
Pancreatic cancer (163)
Parkinson's disease (234)
Partnered (16)
Patents (306)
Patient recruitment (328)
Peanut (45)
People (30336)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15558)
Phase 2 (20458)
Phase 3 (12984)
Pipeline (3298)
Policy (95)
Postmarket research (883)
Preclinical (6589)
Press Release (38)
Prostate cancer (154)
Psychedelics (50)
Radiopharmaceuticals (243)
Rare diseases (649)
Real estate (1567)
Recruiting (15)
Regulatory (10146)
Reports (19)
Research institute (1044)
Resumes & cover letters (38)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (123)
Series A (185)
Series B (136)
Service/supplier (1)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (120)
Sponsored (15)
Startups (2034)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (20)
The Weekly (62)
Vaccines (341)
Venture capital (69)
Weight loss (176)
Women's health (26)
Worklife (2)
Date
Today (2)
Last 7 days (346)
Last 30 days (1304)
Last 365 days (18223)
2026 (1687)
2025 (18507)
2024 (20977)
2023 (22992)
2022 (27609)
2021 (28735)
2020 (24227)
2019 (17484)
2018 (12649)
2017 (14326)
2016 (12385)
2015 (14953)
2014 (10885)
2013 (7862)
2012 (7925)
2011 (7977)
2010 (7764)
Location
Africa (190)
Alabama (67)
Alaska (3)
Arizona (74)
Arkansas (6)
Asia (18741)
Australia (3221)
California (7176)
Canada (1893)
China (778)
Colorado (281)
Connecticut (253)
Delaware (239)
Europe (40390)
Florida (933)
Georgia (212)
Hawaii (2)
Idaho (19)
Illinois (404)
India (36)
Indiana (169)
Iowa (10)
Japan (227)
Kansas (81)
Kentucky (9)
Louisiana (8)
Maine (57)
Maryland (755)
Massachusetts (5644)
Michigan (110)
Minnesota (255)
Mississippi (3)
Missouri (34)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1722)
New Mexico (14)
New York (1784)
North Carolina (853)
North Dakota (7)
Northern California (3536)
Ohio (186)
Oklahoma (11)
Oregon (24)
Pennsylvania (1301)
Puerto Rico (9)
Rhode Island (25)
South America (256)
South Carolina (10)
Southern California (2838)
Tennessee (42)
Texas (920)
United States (23841)
Utah (99)
Virginia (143)
Washington D.C. (39)
Washington State (606)
West Virginia (1)
Wisconsin (45)
293,316 Results for "mast therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs
January 16, 2026
·
6 min read
Press Releases
Celldex Announces Initial Positive Results from Phase 1 Trial of CDX-622 Demonstrating Favorable Safety and PK Profile and Sustained Mast Cell Inhibition
October 31, 2025
·
7 min read
Press Releases
Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases
June 13, 2025
·
4 min read
Allegria Therapeutics Announces Seed Financing to Advance Pipeline of Novel and Selective Therapeutic Approaches for Mast Cell-Mediated Diseases
Allegria Therapeutics, a Swiss biotech company redefining the treatment landscape of therapeutics for mast cell-mediated diseases, announced a Seed Financing of USD 3.5 Million by founding investor Forty51 Ventures.
May 6, 2024
·
2 min read
Press Releases
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
August 22, 2025
·
6 min read
Press Releases
Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease
May 5, 2025
·
8 min read
Drug Development
Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile
Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing AK006 for the treatment of mast cell-driven diseases, today announced positive results from the single and multiple ascending Phase 1 study of intravenous (IV) AK006 in healthy volunteers
June 25, 2024
·
6 min read
Biotech Bay
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024
Jasper Therapeutics, Inc. today announced presentations of data from its preclinical and healthy volunteer studies of briquilimab, as well as trial-in-progress presentations from its BEACON and SPOTLIGHT clinical studies, at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024, taking place May 31 – June 3 in Valencia, Spain.
May 30, 2024
·
9 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Jasper Therapeutics Appoints Jeet Mahal as Chief Executive Officer to Lead Next Phase of Clinical Growth
January 8, 2026
·
7 min read
1 of 29,332
Next
